Artificial intelligence has emerged as a double-edged sword for pharmaceutical companies, helping to develop new cures while also creating obstacles to obtaining drug patents potentially worth billions. A vast trove of AI creations would make it increasingly difficult for companies to convince patent offices around the world their inventions are novel, minimizing their incentives to invest the massive sums necessary to find new treatments, attorneys say.
Read the full article: AI Helps Pharma Find New Drugs But Imperils Lucrative Patents //
Source: https://news.bloomberglaw.com/ip-law/ai-helps-pharma-find-new-drugs-but-imperils-lucrative-patents